Who is sponsoring NCT07461597?

NCT07461597 is sponsored by MAAElgammal.

What drugs are being tested in NCT07461597?

Interventions in NCT07461597: Digital Intraoral Scanning.

What condition does NCT07461597 study?

NCT07461597 studies Monolithic Zirconia Endocrowns.

Is NCT07461597 still recruiting?

NCT07461597 is currently completed. Last updated 10 March 2026.

Last reviewed 2026-03-10 · How we verify

NCT07461597

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Fabrication Monolithic Zirconia Endocrown on Marginal Integrity

Completed NA Last updated 10 March 2026

What this trial tests

NA trial testing Digital Intraoral Scanning in Monolithic Zirconia Endocrowns in 22 participants. Completed in 1 March 2024.

Timeline

1 January 2023

Primary endpoint
1 January 2023

1 March 2024

Quick facts

Lead sponsor	MAAElgammal
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	22
Start date	1 January 2023
Primary completion	1 January 2023
Estimated completion	1 March 2024
Sites	1 location across Egypt

Drugs / interventions tested

Digital Intraoral Scanning

Conditions studied

Monolithic Zirconia Endocrowns — all drugs for Monolithic Zirconia Endocrowns →

Sponsor

MAAElgammal

Who can join

Adults 15 to 50, any sex, with Monolithic Zirconia Endocrowns. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the marginal integrity and patient satisfaction of two different impression techniques for monolithic zirconia endocrowns.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07461597 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by MAAElgammal
Last refreshed: 10 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07461597.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing